Invest
Healthcare Services company Dr. Lal PathLabs announced Q4FY24 results:
- Revenue increased by 11.1% in Q4FY24
- EBITDA increased by 25.1% with a margin of 26.5%
- PAT increased by 50.8% with a margin for of 15.7%
| CLIENT NAME | DEAL TYPE | ACTION | DATE | AVG. PRICE | QUANTITY | EXCHANGE |
|---|---|---|---|---|---|---|
| ISHARES CORE MSCI EMERGING MARKETS ETF | Block | Purchase | 2022-10-25 | 2550.9 | 69319 | BSE |
| ISHARES MSCI INDIA SMALL-CAP ETF | Block | Purchase | 2022-10-25 | 2550.9 | 12949 | BSE |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | Block | Sell | 2022-10-25 | 2550.9 | 69319 | BSE |
| Financials( ₹ in Cr) | Dr Lal Pathlabs Ltd | Max Healthcare Institute Ltd | Apollo Hospitals Enterprise Ltd | Fortis Healthcare Ltd | Global Health Ltd |
|---|---|---|---|---|---|
| Price | 2,780.70 | 940.65 | 6,185.70 | 475.35 | 1,308.30 |
| % Change | 1.19 | 2.16 | -0.11 | -0.62 | 2.54 |
| Mcap ₹ Cr | 23,212.73 | 91,422.90 | 88,941.09 | 35,886.93 | 35,128.77 |
| Revenue TTM ₹ Cr | 2,226.64 | 4,831.37 | 16,612.50 | 6,537.06 | 2,694.25 |
| Net Profit TTM ₹ Cr | 362.29 | 1,103.51 | 887.50 | 632.98 | 326.08 |
| PE TTM | 64.84 | 86.65 | 99.11 | 61.16 | 73.37 |
| 1 Year Return | 26.05 | 55.92 | 20.65 | 55.83 | 99.44 |
| ROCE | 25.58 | 13.85 | 14.16 | 7.51 | 16.49 |
| ROE | 20.61 | 16.12 | 15.04 | 6.79 | 16.13 |
Equity Capital: 1,849.29 Cr FV: 10.00
| Period | MF Net Purchase / (sold) | FII Net |
|---|---|---|
| LAST 1M | 29,542.69 | 26,564.54 |
| LAST 3M | 107,300.08 | -872.81 |
| LAST 6M | 187,950.75 | 839.71 |
| LAST 12M | 304,454.24 | 86,051.23 |
| Date | Action Type | Ratio |
|---|---|---|
| Jun 10, 2024 | Dividend | 60 |
| Feb 13, 2024 | Dividend | 120 |
| Aug 11, 2023 | Dividend | 60 |
| AGM Date (Month) | : | Sep |
| Face Value Equity Shares | : | 10 |
| Market Lot Equity Shares | : | 1 |
| BSE Code | : | 539524 |
| NSE Code | : | LALPATHLAB |
| Book Closure Date (Month) | : | |
| BSE Group | : | A |
| ISIN | : | INE600L01024 |
FAQ’s on Dr Lal Pathlabs Ltd SharesYou can buy Dr Lal Pathlabs Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Dr Lal Pathlabs Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Jun 28, 2024 03:57 PM the closing price of Dr Lal Pathlabs Ltd was Rs.2,780.70.
The latest PE ratio of Dr Lal Pathlabs Ltd as of Jun 28, 2024 03:57 PM is 64.84
The latest PB ratio of Dr Lal Pathlabs Ltd as of Jun 28, 2024 03:57 PM is 0.08
The 52-week high of Dr Lal Pathlabs Ltd share price is Rs. 2,889.00 while the 52-week low is Rs. 1,943.70
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jun 28, 2024 03:57 PM, the market cap of Dr Lal Pathlabs Ltd stood at Rs. 23,212.73 Cr.
